Comparison of Methodology Proposed by the SFAR for the Detection by Videoconference of Obstructive Sleep Apnea.
NCT ID: NCT05711329
Last Updated: 2024-04-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
210 participants
OBSERVATIONAL
2024-11-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Telemonitoring on CPAP Treatment Compliance in Obstructive Sleep Apnea (OSA) Patients
NCT02517346
Enhanced Respiratory Polygraphy in Suspected OSA
NCT05949853
Internal and Predictive Validity of Epworth Sleepiness Scale to Evaluate Vigilance of Patient Treated for Obstructive Sleep Apnea Syndrome.
NCT03629834
Data Collection Study to Review Novel Methods for Diagnosing Obstructive Sleep Apnea
NCT06930404
Usefulness of a Telemedicine System for OSA Patients Follow-up With High Cardiovascular Risk
NCT01226641
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Other methods, such as a predictive score, also exist. The accuracy of the French method compared to PSG and the predictive scores is to be determined.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All patients
Patients in this group will serve to validate the accuracy of the French method to detect OSA patients in comparison with PSG results.
Accuracy
We will validate the accuracy of the method proposed by the SFAR to detect OSA patients via videoconference (in comparison with the results of the PSG).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Accuracy
We will validate the accuracy of the method proposed by the SFAR to detect OSA patients via videoconference (in comparison with the results of the PSG).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Astes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eric DEFLANDRE, MD, PhD, FCCP, FAHA, FAACD
Head of Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric Deflandre, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Astes
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Visio-PSG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.